Osteo Arthritis Shoulders
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
ExactechFL - Gainesville
1 programExactech Shoulder Post Market Clinical Follow-up StudyN/A1 trial
Active Trials
Innovation PharmaceuticalsMA - Wakefield
1 programreverse total shoulder arthroplastyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Anika TherapeuticsMonovisc
Innovation Pharmaceuticalsreverse total shoulder arthroplasty
ExactechExactech Shoulder Post Market Clinical Follow-up Study
Clinical Trials (3)
Total enrollment: 20,175 patients across 3 trials
MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis
Start: Dec 2019Est. completion: Mar 202125 patients
N/ACompleted
Reverse Total Shoulder Arthroplasty: A Data Analysis on Patients Undergoing Reverse Total Shoulder Arthroplasty
Start: Dec 2017Est. completion: Dec 2020150 patients
N/AUnknown
Exactech Shoulder Post Market Clinical Follow-up Study
Start: Jul 2007Est. completion: Dec 203120,000 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 20,175 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.